gavo-cel
Generic: gavocabtagene autoleucel·Code: TC-210
gavo-cel: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| TCR2 THERAPEUTICS INC. (TCRR) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer
Frequently asked questions
Who is developing gavo-cel?
gavo-cel is being developed by TCR2 THERAPEUTICS INC..
How many clinical trials involve gavo-cel?
BioSniper tracks 1 clinical trial involving gavo-cel.
Get deeper analysis on gavo-cel
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis